MyFinsight
Home
About
Contact
elv: the income statement
Download
Download image
Carelon Services
Segment
$191M
(-4.98%↓ Y/Y)
Carelon Rx Segment
$4M
(100.00%↑ Y/Y)
Premiums Earned Net
$1,762M
(159.12%↑ Y/Y)
Total Carelon
$195M
Health Benefits
Segment
$1,942M
(6.12%↑ Y/Y)
Operating Segments-Total
Carelon
$1,762M
Health Benefits
Segment-Operating Segments
$40,304M
(10.58%↑ Y/Y)
Product and service
revenue-Service Fees
$2,137M
(5.64%↑ Y/Y)
Product and service
revenue-Product
$6,159M
(4.62%↑ Y/Y)
Premiums
$41,791M
(13.53%↑ Y/Y)
Intersegment Elimination
-$275M
(13.79%↑ Y/Y)
Net investment
income
$625M
(13.43%↑ Y/Y)
Total operating
revenue
$50,087M
(12.00%↑ Y/Y)
Total revenues
$50,711M
(12.43%↑ Y/Y)
Net losses on
financial instruments
-$1M
(99.20%↑ Y/Y)
Income before income
tax expense
$1,406M
(2.40%↑ Y/Y)
Total expenses
$49,305M
(12.74%↑ Y/Y)
Net loss
attributable to...
-$2M
(75.00%↑ Y/Y)
Net income
$1,187M
(17.76%↑ Y/Y)
Income tax expense
$219M
(-40.00%↓ Y/Y)
Amortization of other
intangible assets
$162M
(32.79%↑ Y/Y)
Interest expense
$351M
(17.00%↑ Y/Y)
Operating expense
$5,272M
(0.06%↑ Y/Y)
Cost of products sold
$5,380M
(5.64%↑ Y/Y)
Benefit expense
$38,140M
(15.75%↑ Y/Y)
Shareholders net income
$1,189M
(17.03%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Apex-Header-svg
Elevance Health, Inc. (ELV)
Apex-Header-svg
Elevance Health, Inc. (ELV)